ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 126 filers reported holding ANAPTYSBIO INC in Q2 2018. The put-call ratio across all filers is 2.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $25,700,000 | +263.5% | 1,195,336 | +139.1% | 0.28% | +50.0% |
| Q1 2020 | $7,070,000 | -56.5% | 500,000 | -50.0% | 0.18% | -43.0% |
| Q4 2019 | $16,250,000 | -34.2% | 1,000,000 | +321.4% | 0.32% | -53.3% |
| Q1 2018 | $24,696,000 | -67.6% | 237,281 | -68.6% | 0.69% | -72.6% |
| Q4 2017 | $76,183,000 | +11.0% | 756,387 | -61.5% | 2.52% | +92.6% |
| Q3 2017 | $68,660,000 | +201.3% | 1,964,538 | +106.3% | 1.31% | +14.3% |
| Q2 2017 | $22,788,000 | -6.9% | 952,269 | +8.0% | 1.15% | -17.7% |
| Q1 2017 | $24,474,000 | – | 881,957 | – | 1.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |